Free Trial

Zevra Therapeutics (ZVRA) SEC Filings & 10K Form

Zevra Therapeutics logo
$8.13 +0.48 (+6.27%)
Closing price 02/4/2025 04:00 PM Eastern
Extended Trading
$8.14 +0.01 (+0.14%)
As of 02/4/2025 07:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Zevra Therapeutics SEC Filings

DateFilerForm TypeView
02/03/2025
4:19 PM
McFarlane Neil F. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
4:20 PM
Clifton R. LaDuane (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
4:22 PM
Schafer Joshua (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
4:23 PM
Thompson Rahsaan (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
4:24 PM
Sangiovanni Timothy J. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
4:28 PM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:53 PM
Nantahala Capital Management, LLC (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
Form SCHEDULE 13G/A
11/04/2024
1:15 PM
VANGUARD GROUP INC (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
Form SC 13G/A
10/16/2024
3:46 PM
Watton Corey Michael (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:17 PM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
3:54 PM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form 424B5
07/17/2024
4:54 PM
Clifton R. LaDuane (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
3:39 PM
Anderson Thomas (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
3:37 PM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
3:23 PM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
07/09/2024
8:23 AM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
4:11 PM
Thompson Rahsaan (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/25/2024
4:13 PM
Thompson Rahsaan (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
11:15 PM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form EFFECT
05/15/2024
8:15 PM
Watton Corey Michael (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
8:18 PM
Calder Douglas W (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
8:20 PM
FAVORITO TAMARA A (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
8:28 PM
DIXON WENDY L (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
8:31 PM
Bode John B (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
8:05 PM
Anderson Thomas (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
8:13 PM
Shih Alvin (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:54 AM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
6:49 AM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form DEFA14A
04/10/2024
3:23 PM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form 424B3
04/10/2024
6:46 AM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2024
11:15 PM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form EFFECT
04/05/2024
6:39 PM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form S-3/A
04/01/2024
4:27 PM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2024
7:28 PM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
6:34 AM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
7:24 AM
ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ZVRA) was last updated on 2/5/2025 by MarketBeat.com Staff
From Our Partners